Silver Touch Technologies Limited, a leader in innovative technology solutions, is thrilled to announce the launch of its cutting-edge AI-powered product, ChatGMP, through its subsidiary, Ai4Pharma Tech Limited. This state-of-the-art solution is designed specifically for the pharmaceutical industry, aiming to revolutionize communication within GMP-regulated environments. ChatGMP is an AI-driven conversational platform built on Generative AI technology. Unlike traditional chatbots, it is meticulously crafted to comprehend the unique language, compliance requirements, and operational intricacies of pharma teams, making communication more efficient and compliant.

Key Features of ChatGMP

• Comprehensive Data Access: ChatGMP aggregates inspection data from multiple FDA sources, historical compliance records, and competitor profiles. It eliminates the need for professionals to search across various platforms or manually gather information, as everything is readily accessible within a single platform.

• Smart Query Functionality: ChatGMP offers advanced query capabilities. Users can easily ask complex questions such as, “What were the top FDA 483 observations in the last year for sterile facilities?” The platform understands these queries and delivers structured and contextual answers that save valuable time.

• Versatile Data Analysis: More than just a data aggregation tool, ChatGMP also empowers users to analyze the data. It helps identify trends, flags risk areas, and allows for comparison of competitor performance across regions or product types, thus enhancing strategic decision-making.

• Time Efficiency and Quick Decision-Making: By automating tedious data collection and simplifying analysis, ChatGMP significantly reduces the time it takes to arrive at crucial compliance decisions. This time-saving functionality directly translates to faster actions and greater efficiency within pharmaceutical operations.

Statement from Mr. Amish Vyas, CEO of Ai4Pharma Tech

“The launch of ChatGMP marks a significant milestone in our commitment to leveraging AI for the pharmaceutical industry. We are excited to offer a tool that not only enhances communication but also ensures the highest standards of accuracy and compliance in GMP-regulated environments,” said Mr. Amish Vyas, Co-Founder and CEO at Ai4Pharma.

This launch signifies a crucial development in Ai4Pharma’s journey toward improving pharma outcomes through the application of artificial intelligence. With ChatGMP, pharmaceutical teams now have the ability to streamline internal communication, enhance decision-making, and maintain strict compliance with regulatory standards—all through the use of Generative AI.

Availability

The product launch information is also available on the company’s official website at Silver Touch Technologies Investors Page.

Silver Touch Technologies continues to push the boundaries of innovation and technology to offer state-of-the-art solutions that cater to the needs of various industries. Through products like ChatGMP, the company demonstrates its commitment to transforming pharmaceutical operations, making them smarter, more compliant, and highly efficient.

The launch of ChatGMP is another milestone for Ai4Pharma and Silver Touch Technologies in their efforts to enhance pharma industry operations using advanced technologies.

This announcement will be updated in the company’s records, and stakeholders are encouraged to review the progress of this groundbreaking product in due course.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.